EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibiting HIF ‐1α‐Induced miR ‐663b Improves Pulmonary Arterial Hypertension by Reducing Dysfunctions of PASMCs Through Repressing Sirt1‐ ZBP1 ‐Mediated PANoptosis

Le Shen, Honghong Ma, Yang Yu, Yan Xu, Qun Yuan, Xia Zhao, Bing Zhuan iD

Journal of Cellular and Molecular Medicine · 2026-08 · 30 (15)

DOI: 10.1111/jcmm.71285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 03.08.2026. Verfasst von Le Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China. Hauptthemen laut MEDLINE: MicroRNAs, Hypoxia-Inducible Factor 1, alpha Subunit, Sirtuin 1, Myocytes, Smooth Muscle. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ningxia Natural Science Foundation, Natural Science Foundation of Ningxia Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a progressive disease characterised by vascular remodelling. Inflammatory responses and oxidative stress have been shown to contribute to its progression. This study investigated the effects of a novel HIF‐1α‐miR‐663b axis on pulmonary arterial smooth muscle inflammation, oxidative stress and apoptosis in a monocrotaline (MCT)‐induced PAH rat model. A PAH rat model was constructed via MCT injection; moreover, miR‐663b inhibitors were administered to inhibit miR‐663b. PASMCs were cultured under hypoxic conditions to establish an in vitro PAH model. The data revealed that miR‐663b was highly expressed in PAH rats and hypoxia‐induced PASMC models. Overexpression of miR‐663b exacerbated hypoxia‐induced proliferation, apoptosis, migration and inflammation in PASMCs. Conversely, miR‐663b inhibition reversed hypoxia‐induced dysfunction in PASMCs. ZBP1 downregulation dampened miR‐663b upregulation‐mediated dysfunctions in PASMCs. In vivo experiments revealed that miR‐663b inhibitors mitigated pulmonary arterial remodelling, inflammation and PANoptosis in MCT‐induced PAH rats. HIF‐1α expression was upregulated in hypoxia‐induced PASMCs. ChIP–qPCR and dual‐luciferase reporter gene assays confirmed that HIF‐1α transcriptionally regulated and promoted miR‐663b expression. Upregulation of miR‐663b inhibited AMPK/Sirt1 signalling pathway activation and promoted ZBP1‐mediated PANoptosis. However, miR‐663b inhibitors reversed hypoxia‐induced PANoptosis in PASMCs. The protective effects of miR‐663b inhibitors on PASMCs and their inhibitory effects on PANoptosis were significantly weakened by treatment with an AMPK inhibitor or a Sirt1 inhibitor. Collectively, these findings suggest that inhibiting HIF‐1α‐mediated miR‐663b expression improves PAH by reducing PASMC dysfunction through the attenuation of inflammatory responses, oxidative stress and apoptosis in PASMCs and the activation of the AMPK/Sirt1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHypoxia-Inducible Factor 1, alpha SubunitSirtuin 1Myocytes, Smooth MusclePulmonary ArteryRNA-Binding ProteinsPulmonary Arterial HypertensionAnimalsMaleRatsRats, Sprague-DawleyApoptosisDisease Models, AnimalSignal TransductionCell ProliferationOxidative Stress

Stichwörter der Autor:innen

AMPKHIF‐1αPANoptosisPASMCsmiR‐663bpulmonary artery hypertension

Substanzen

MicroRNAsHypoxia-Inducible Factor 1, alpha SubunitSirtuin 1RNA-Binding ProteinsHif1a protein, ratSirt1 protein, rat

Autor:innen und Institutionen

  • Department of Respiratory Medicine, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
  • Department of Respiratory Medicine, Third Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.
  • Ningxia Medical University, Yinchuan, Ningxia, China.
  • Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.

ORCID-Profile: Bing Zhuan

Förderung

  • National Natural Science Foundation of China
  • Ningxia Natural Science Foundation
  • Natural Science Foundation of Ningxia Province

Zitieren

APA

Shen, L., Ma, H., Yu, Y., Xu, Y., Yuan, Q., Zhao, X., & Zhuan, B. (2026). Inhibiting HIF ‐1α‐Induced miR ‐663b Improves Pulmonary Arterial Hypertension by Reducing Dysfunctions of PASMCs Through Repressing Sirt1‐ ZBP1 ‐Mediated PANoptosis. Journal of Cellular and Molecular Medicine, 30(15). https://doi.org/10.1111/jcmm.71285

Vancouver

Shen L, Ma H, Yu Y, Xu Y, Yuan Q, Zhao X, et al. Inhibiting HIF ‐1α‐Induced miR ‐663b Improves Pulmonary Arterial Hypertension by Reducing Dysfunctions of PASMCs Through Repressing Sirt1‐ ZBP1 ‐Mediated PANoptosis. Journal of Cellular and Molecular Medicine. 2026;30(15). doi:10.1111/jcmm.71285

BibTeX
@article{Shen2026,
  author = {Shen, Le and Ma, Honghong and Yu, Yang and Xu, Yan and Yuan, Qun and Zhao, Xia and Zhuan, Bing},
  title = {Inhibiting HIF ‐1α‐Induced miR ‐663b Improves Pulmonary Arterial Hypertension by Reducing Dysfunctions of PASMCs Through Repressing Sirt1‐ ZBP1 ‐Mediated PANoptosis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {15},
  doi = {10.1111/jcmm.71285}
}
Kostenlos starten →